
Gregory J. Tryder
Supervisory Patent Examiner (ID: 19032, Phone: (571)270-7365 , Office: P/2617 )
| Most Active Art Unit | 2629 |
| Art Unit(s) | 2600, 2617, 2692, 2626, 2629 |
| Total Applications | 245 |
| Issued Applications | 113 |
| Pending Applications | 0 |
| Abandoned Applications | 133 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 833565
[patent_doc_number] => 07396855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Compositions and products containing S-equol, and methods for their making'
[patent_app_type] => utility
[patent_app_number] => 10/625934
[patent_app_country] => US
[patent_app_date] => 2003-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 14946
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396855.pdf
[firstpage_image] =>[orig_patent_app_number] => 10625934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/625934 | Compositions and products containing S-equol, and methods for their making | Jul 23, 2003 | Issued |
Array
(
[id] => 7227365
[patent_doc_number] => 20050255391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds'
[patent_app_type] => utility
[patent_app_number] => 10/522212
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7996
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255391.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522212 | Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds | Jul 14, 2003 | Abandoned |
Array
(
[id] => 7173373
[patent_doc_number] => 20050203172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Novel compounds'
[patent_app_type] => utility
[patent_app_number] => 10/521727
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7492
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521727 | Novel compounds | Jul 14, 2003 | Abandoned |
Array
(
[id] => 917718
[patent_doc_number] => 07323572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-29
[patent_title] => 'Process for controlling the hydrate mix of a compound'
[patent_app_type] => utility
[patent_app_number] => 10/601355
[patent_app_country] => US
[patent_app_date] => 2003-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4530
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/323/07323572.pdf
[firstpage_image] =>[orig_patent_app_number] => 10601355
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/601355 | Process for controlling the hydrate mix of a compound | Jun 22, 2003 | Issued |
Array
(
[id] => 397677
[patent_doc_number] => 07294646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-13
[patent_title] => 'Maxi-k channel blockers, methods of use and process for making the same'
[patent_app_type] => utility
[patent_app_number] => 10/511731
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10978
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511731 | Maxi-k channel blockers, methods of use and process for making the same | Jun 12, 2003 | Issued |
Array
(
[id] => 7429061
[patent_doc_number] => 20040230060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Process for preparing 1,5-diaryl-3-substituted pyrazoles'
[patent_app_type] => new
[patent_app_number] => 10/460601
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5169
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20040230060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10460601
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460601 | Process for preparing 1,5-diaryl-3-substituted pyrazoles | Jun 11, 2003 | Issued |
Array
(
[id] => 7994495
[patent_doc_number] => RE043038
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2011-12-20
[patent_title] => 'Compound having antitumor activity and process for producing the same'
[patent_app_type] => reissue
[patent_app_number] => 13/092127
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8856
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/043/RE043038.pdf
[firstpage_image] =>[orig_patent_app_number] => 13092127
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/092127 | Compound having antitumor activity and process for producing the same | Jun 5, 2003 | Issued |
Array
(
[id] => 7112007
[patent_doc_number] => 20050209463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Novel compound having antitumor activity and process for producing the same'
[patent_app_type] => utility
[patent_app_number] => 10/516743
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8783
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516743
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516743 | Compound having antitumor activity and process for producing the same | Jun 5, 2003 | Issued |
Array
(
[id] => 864929
[patent_doc_number] => 07368464
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-06
[patent_title] => 'Preparation for the production of 1,2,4-triazolylmethyl-oxiranes'
[patent_app_type] => utility
[patent_app_number] => 10/516727
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4513
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368464.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516727 | Preparation for the production of 1,2,4-triazolylmethyl-oxiranes | Jun 5, 2003 | Issued |
Array
(
[id] => 5694830
[patent_doc_number] => 20060154977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Therapeutic molecules and methods-1'
[patent_app_type] => utility
[patent_app_number] => 10/517264
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 31207
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517264
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517264 | Therapeutic molecules and methods-1 | Jun 5, 2003 | Issued |
Array
(
[id] => 5733609
[patent_doc_number] => 20060258726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => '1,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases'
[patent_app_type] => utility
[patent_app_number] => 10/511737
[patent_app_country] => US
[patent_app_date] => 2003-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14260
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258726.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511737 | 1,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases | Jun 2, 2003 | Abandoned |
Array
(
[id] => 7251864
[patent_doc_number] => 20050272951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Process for the separation of the water produced in the catalytic oxidation of aromatic hydrocarbons to polycarboxylic aromatic acids'
[patent_app_type] => utility
[patent_app_number] => 10/518070
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3454
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518070 | Process for the separation of the water produced in the catalytic oxidation of aromatic hydrocarbons to polycarboxylic aromatic acids | May 29, 2003 | Abandoned |
Array
(
[id] => 7075361
[patent_doc_number] => 20050148629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Compounds useful in the treatment of anthrax and inhibiting lethal factor'
[patent_app_type] => utility
[patent_app_number] => 10/509972
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6980
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509972 | Compounds useful in the treatment of anthrax and inhibiting lethal factor | May 22, 2003 | Issued |
Array
(
[id] => 7005860
[patent_doc_number] => 20050171173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/514539
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16041
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514539
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514539 | Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors | May 15, 2003 | Issued |
Array
(
[id] => 7352277
[patent_doc_number] => 20040048346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Synthesis of chiral intermediates useful in preparing pharmacologically active compounds'
[patent_app_type] => new
[patent_app_number] => 10/416171
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2982
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416171 | Synthesis of chiral intermediates useful in preparing pharmacologically active compounds | May 7, 2003 | Abandoned |
Array
(
[id] => 7110670
[patent_doc_number] => 20050208125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatmetn of central nervous system disturbances'
[patent_app_type] => utility
[patent_app_number] => 10/513859
[patent_app_country] => US
[patent_app_date] => 2003-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12582
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208125.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513859
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513859 | Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatmetn of central nervous system disturbances | May 6, 2003 | Abandoned |
Array
(
[id] => 7281373
[patent_doc_number] => 20040063750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'High-density lipoprotein-cholesterol level elevating agent'
[patent_app_type] => new
[patent_app_number] => 10/416239
[patent_app_country] => US
[patent_app_date] => 2003-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28135
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416239
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416239 | High-density lipoprotein-cholesterol level elevating agent | May 5, 2003 | Abandoned |
Array
(
[id] => 919813
[patent_doc_number] => 07320994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-22
[patent_title] => 'Triazole derivatives as tachykinin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/512249
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60925
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/320/07320994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512249 | Triazole derivatives as tachykinin receptor antagonists | Apr 21, 2003 | Issued |
Array
(
[id] => 7020391
[patent_doc_number] => 20050222410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Inhibitors of histone deacetylase'
[patent_app_type] => utility
[patent_app_number] => 10/512808
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24920
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222410.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512808
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512808 | Inhibitors of histone deacetylase | Apr 16, 2003 | Abandoned |
Array
(
[id] => 7470066
[patent_doc_number] => 20040102507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods'
[patent_app_type] => new
[patent_app_number] => 10/414660
[patent_app_country] => US
[patent_app_date] => 2003-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 27227
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102507.pdf
[firstpage_image] =>[orig_patent_app_number] => 10414660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/414660 | Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | Apr 15, 2003 | Issued |